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Abstract  45 
Rapid and effective neural transmission of information requires correct axonal 46 
myelination. Modifications in myelination alter axonal capacity to transmit electric 47 
impulses and enable pathological conditions. In the central nervous system (CNS), 48 
oligodendrocytes (OLs) myelinate axons, a complex process involving various cellular 49 
interactions. However, we know little about the mechanisms that orchestrate correct 50 
myelination. Here, we demonstrate that OLs express R-Ras1 and R-Ras2. Using female 51 
and male mutant mice to delete these proteins, we find that activation of the PI3K/Akt 52 
and Erk1/2-MAPK pathways is weaker in mice lacking one or both of these GTPases, 53 
suggesting that both proteins coordinate the activity these two pathways. Loss of R-54 
Ras1 and/or R-Ras2 diminishes the number of OLs in major myelinated CNS tracts and 55 
increases the proportion of immature OLs. In R-Ras1-/- and R-Ras2-/- null mice, OLs 56 
show aberrant morphologies and fail to differentiate correctly into myelin-forming 57 
phenotypes. The smaller OL population and abnormal OL maturation induce severe 58 
hypomyelination, with shorter nodes of Ranvier in R-Ras1-/- and/or R-Ras2-/- mice. 59 
These defects explain the slower conduction velocity of myelinated axons we observed 60 
in the absence of R-Ras1 and R-Ras2. Together, these results suggest that R-Ras1 and 61 
R-Ras2 are upstream elements that regulate the survival and differentiation of 62 
progenitors into OLs through the PI3K/Akt and Erk1/2-MAPK pathways for proper 63 
myelination. 64 
  65 
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Significance Statement  66 
In this study, we show that R-Ras1 and R-Ras2 play essential roles in regulating 67 
myelination in vivo and control fundamental aspects of oligodendrocyte survival and 68 
differentiation through synergistic activation of PI3K/Akt and Erk1/2-MAPK signaling. 69 
Mice lacking R-Ras1 and/or R-Ras2 show a diminished oligodendrocyte population 70 
with a higher proportion of immature oligodendrocytes, explaining the observed 71 
hypomyelination in main CNS tracts. In vivo electrophysiology recordings demonstrate 72 
a slower conduction velocity of nerve impulses in the absence of R-Ras1 and R-Ras2. 73 
Thus, R-Ras1 and R-Ras2 are essential for proper axonal myelination and accurate 74 
neural transmission.  75 
  76 
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Introduction  77 
Mammalian plasma membranes from specialized glial cells generate myelin as 78 
oligodendrocytes in the central nervous system and Schwann cells in the peripheral 79 
nervous system. Axonal myelination is essential to facilitate fast, saltatory conduction 80 
of action potentials. Changes in myelin structure, such as sheath thickness and internode 81 
length, can alter axonal conduction velocities, which may induce pathologies like 82 
leukodystrophies and peripheral neuropathies (Suter and Scherer, 2003; Boespflug-83 
Tanguy et al., 2008). 84 
During development, oligodendrocyte progenitor cells (OPCs), which differentiate into 85 
OLs, arise along the caudorostral axis of the ventricular neuro-epithelium of the neural 86 
tube at multiple restricted foci distributed along the dorsoventral axis to colonize the 87 
entire CNS (de Castro F., 2013; Ono et al., 2017). OPCs then differentiate into mature 88 
OLs forming myelin (Nave and Werner, 2014). Various intrinsic and extrinsic cues, like 89 
specific growth factors, protein kinases and extracellular matrix proteins regulate the 90 
spatial and temporal patterns of OL differentiation by modifying gene expression and 91 
cell morphology (Bauer et al., 2009; Emery, 2010).  92 
Among these factors, PI3K/Akt and Erk1/2-MAPK signaling pathways may control OL 93 
survival, migration, differentiation and myelination (Ness et al., 2002; Romanelli et al., 94 
2009; Ishii et al., 2014; Murcia-Belmonte et al., 2014; Gaesser and Fyffe-Maricich, 95 
2016; Murcia-Belmonte et al., 2016). Indeed, mutant animals that have constitutively-96 
active PI3K-Akt-mTOR pathways in their OPCs and OLs show dramatically enhanced 97 
myelin formation but not changes in OL generation (Flores et al., 2008; Goebbels et al., 98 
2010; Harrington et al., 2010). In contrast, inhibition of effectors of the PI3K/Akt 99 
pathway such as mTOR causes defective OL differentiation both in vitro and in vivo 100 
(Tyler et al., 2009; Wahl et al., 2014). Erk1/2 signaling controls thickness and 101 
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maintenance of CNS myelin (Wahl et al., 2014 Ishii 2014), and its inactivation produces 102 
a delay in the differentiation and maturation of OLs (Fyffe-Maricich et al., 2011). 103 
Hyperactivation of the Erk1/2-MAPK pathway during development drives a transient 104 
OPC hyperproliferation without affecting their differentiation or the final number of 105 
mature OLs (Ishii et al., 2013). In addition, Erk1/2 activation in OLs drives sheath 106 
expansion (Jeffries et al., 2016) (Jeffries et al., 2016). It is known that there is cross-talk 107 
between PI3K/Akt and Erk1/2-MAPK (Gaesser and Fyffe-Maricich, 2016; Furusho et 108 
al., 2017), though little is known about the mechanisms that mediate the coordinated 109 
activity of signaling in these two molecular pathways. 110 
One candidate is the Ras superfamily of GTP-binding proteins. These membrane-111 
anchored intracellular signal transducers that act through both PI3K/Akt and Erk1/2-112 
MAPK pathways (Arimura and Kaibuchi, 2007) to influence various cell functions, 113 
including proliferation, differentiation and cell survival (Karnoub and Weinberg, 2008; 114 
Pylayeva-Gupta et al., 2011). Members of the classic Ras subfamily (Hras, Kras and 115 
Nras) are frequently mutated and constitutively active in human cancers (Chan et al., 116 
1994). GTPases of the Ras-related (R-Ras) subfamily, composed of R-RAS1 (RRas), R-117 
RAS2 (TC21) and R-RAS3 (also called MRas), are less well understood (Ohba et al., 118 
2000; Colicelli, 2004; Gutierrez-Erlandsson et al., 2013). R-Ras proteins share strong 119 
homology (55-60% amino acid identity) with classic Ras proteins (Drivas et al., 1990; 120 
Colicelli, 2004), and with many effector proteins, including components in PI3K/Akt 121 
and Erk1/2-MAPK pathways (Chan et al., 1994; Graham et al., 1994; Graham et al., 122 
1999; Movilla et al., 1999; Rosario et al., 1999, 2001; Delgado et al., 2009). R-Ras1 and 123 
R-Ras2 are almost ubiquitously expressed (Komatsu and Ruoslahti, 2005; Larive et al., 124 
2012), whereas R-Ras3 expression is more restricted (Kimmelman et al., 2002; Sun et 125 
al., 2006). In the CNS, OLs can express R-Ras1 (Olsen and Ffrench-Constant, 2005), 126 
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however its specific function and putative role with R-Ras2 in myelination remains 127 
unknown. 128 
Here we investigated the role of R-Ras1 and R-Ras2 in OL differentiation for myelin 129 
formation, using three knockout mice: (single R-Ras1 or R-Ras2 null mutants, and a 130 
double null mutant). Different levels of hypomyelination in R-Ras1-/- and R-Ras2-/- mice 131 
indicate that both GTPases are essential for proper myelination. Single and double null 132 
mutant mice showed diminished OL viability from weaker activation of PI3K/Akt and 133 
Erk1/2-MAPK signaling. OL maturation was altered, changing the internode length 134 
(myelin segments between nodes of Ranvier), which strongly decreased axonal 135 
conduction velocity. Overall, our data strongly suggest that R-Ras1 and R-Ras2 are 136 
critical for OL differentiation and CNS myelination through mechanisms using Akt and 137 
Erk pathways.  138 
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Material and Methods  139 
Animals. Mice were housed in specific pathogen–free conditions, in a humidity and 140 
temperature-controlled room on a 12-h light/dark cycle, receiving water and food ad 141 
libitum. All animal procedures were approved by the corresponding institutional ethical 142 
committee (CBMSO) and were performed in accordance with Spanish and European 143 
directives. All efforts were made to minimize animal suffering.  144 
R-Ras1-/- mice were generated at GenoWay Company (France) using the targeting 145 
construction BAL1-HR with a neomycin resistance cassette flanked by FRT sequences 146 
inserted in intron 1 and LoxP sites flanking exons 2 and 6. The construction was 147 
electroporated into embryonic stem cells derived from mouse 129Sv/Pas and selected 148 
by the antibiotic G418. Southern blot was used to verify the correct homologous 149 
recombination.  150 
Heterozygous mice were crossed, and offspring littermates were genotyped by PCR (R-151 
Ras1-/- FW: 5´-GGAGCAAGAGGAGGGAAGGAATGGG-3`, R-Ras1-/- RV: 5´- 152 
CCTTCCAGAGGACTCAGTTCAATCC-3´, R-Ras1+/+ FW: 5`-153 
CGCTCTAGCTGAGCCTCTGT-3´, R-Ras1+/+ RV: 5´- 154 
TACAGGGTCTTGTGGGGAAA-3´). 155 
R-Ras2-/- mice were generated at Lexicon Pharmaceuticals (Texas, USA) and were 156 
derived from embryonic stem cell clone OST361011 with insertion of retroviral 157 
VICTR37 in the middle of intron 1 of R-Ras2. Heterozygous mice were crossed and 158 
offspring littermates were genotyped by PCR (primer 1, 5′-159 
TGAAACAGGATCATGTTGTGGAG-3′; primer 2, 5′-160 
CAGGAGGAGTCCAAGAAGAC-3′; primer 3, 5′-161 
ATAAACCCTCTTGCAGTTGCATC-3′) (Delgado et al., 2009). R-Ras2+/+ and R-162 
Ras2−/− transgenic mice were obtained by crossing of heterozygous mice.  163 
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R-Ras1-/- and R-Ras2-/- mice were kindly provided by Prof. Alarcón (CBMSO, Spain). 164 
Double-knockout R-Ras1-/-;R-Ras2-/- mice were generated by backcrossing individual 165 
lines of R-Ras1-/- and R-Ras2-/-. Animals were maintained in a C57BL6J background. 166 
We have used either, male and female mice to perform the experiments. The morning 167 
the vaginal plug appeared was defined as embryonic day (E) 0.5, and newborn was 168 
defined as postnatal (P) 0. 169 
Western blotting. Tissue samples (optic nerve, spinal cord and corpus callosum of 170 
animals from P30 to P90) were dissected, sonicated in lysis buffer (50 mM Tris pH 8.0, 171 
150 mM NaCl, 1% NP40, 2 mM EDTA, 0.1% SDS, 0.5% desoxycholate, Protease 172 
Inhibition Cocktail; Roche 11697498001, Basel, Switzerland) and phenylmethane 173 
sulfonyl fluoride (PMSF). For detection of phosphorylated proteins, a different buffer 174 
was used (40 mM Tris pH 8.0, 300 mM NaCl, 20% Glycerol, 4 mM EDTA, 0.3% Brij 175 
96, 1 mM PMSF, 2 mM Na3VO4, 10 mM NaF, 1 mM apoprotein, 1 mM benzamidine, 1 176 
mM iodoacetamide, and protease inhibitor cocktail. Lysates were denatured by boiling 177 
for 5 min in protein loading buffer (50 mM Tris–HCl pH 6.8, 2% SDS, 10% glycerol, 178 
1% β-mercaptoethanol (BME), 12.5 mM EDTA and 0.02 % bromophenol blue) and 179 
resolved in 10-12% SDSP-gels in the presence of BME. Gels were run at constant 180 
current starting at 90-100V. After electrophoresis, samples were transferred onto PVDF 181 
membranes using a semi-dry electroblotting system (Transblot-turbo, BioRad, 182 
California, USA) at 1.2 mA/cm2 for 35-40 min. Nonspecific protein binding was 183 
blocked by incubating the membrane with 5% non-fat milk or 5% BSA (for detection of 184 
phosphorylated proteins) in TBS-Tween-20 for 2 h at room temperature. Membranes 185 
were then incubated overnight at 4 °C with the pertinent primary antibodies diluted in 186 
blocking buffer: rabbit anti-R-Ras 1:200 (ab154962), rabbit anti-Caspr 1:250 (Abcam 187 
Cat# ab34151, RRID: AB_869934, Cambridge, UK), mouse anti-GAPDH (G9) 1:1000 188 
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(Santa Cruz Biotechnology Cat# sc-365062, RRID:AB_10847862, Dallas, Texas, 189 
USA), goat anti-MAG (C-19) 1:200 (Santa Cruz Biotechnology Cat# sc-9544, 190 
RRID:AB_670102), rabbit anti-Akt 1:1000 (Cell Signaling Technology Cat# 9272, 191 
RRID:AB_329827, Massachusetts, USA), rabbit anti-P-Akt (S473) 1:1000  (Cell 192 
Signaling Technology Cat# 4060, RRID:AB_2315049), rabbit anti-P-Akt (T308) 193 
1:1000 (Cell Signaling Technology #9275), rabbit anti-phospho S6 (S240/244) 1:1000  194 
(Cell Signaling Technology Cat# 5364, RRID:AB_10694233), rabbit anti-p44/42 195 
MAPK (Erk1/2) 1:1000 (Cell Signaling Technology Cat# 9102, RRID:AB_330744), 196 
rabbit anti-P-p44/42 MAPK (P-Erk1/2) (T202/T204) 1:1000 (Cell Signaling 197 
Technology Cat# 9101, RRID:AB_331646), mouse anti-MBP (aa67-74) 1:200 (Bio-198 
Rad / AbD Serotec Cat# MCA685S, RRID:AB_325009, Raleigh, North Carolina, 199 
USA), mouse anti-TCF-4 clone 6H5-3 1:1000 (Millipore Cat#05-511, 200 
RRID:AB_309772, Missouri, USA) or rabbit anti-Olig2 1:2000 (Millipore Cat# 201 
AB9610, RRID:AB_570666). Specific rabbit antiserum to R-Ras2 (kindly provided by 202 
Prof B. Alarcón) was generated by immunization of New Zealand rabbits with a 203 
purified GST-TC21 fusion protein (Delgado et al., 2009), and used at a 1:200 dilution. 204 
After washing, blots were then incubated for 1 h with appropriate peroxidase-205 
conjugated secondary antibodies (ThermoFisher, Waltham, Massachusetts, USA). 206 
Labeled proteins were detected with the chemiluminescence reagent ECL (Amersham 207 
Biosciences, USA). 208 
Immunohistochemistry. Animals were anesthetized (ketamine/xylazine) and perfused 209 
transcardially with 0.1 M phosphate-buffered saline (PBS; pH 7.4) followed by 4% 210 
paraformaldehyde in PBS. Perfused tissues were removed and postfixed in 4% 211 
paraformaldehyde at 4 °C overnight, then cryoprotected in 30% sucrose in PBS and 212 
embedded and frozen in a 7.5% gelatin in 15% sucrose solution. Then they were 213 
 10 
sectioned on a cryostat to produce 15 μM-thick cryosections on Superfrost Plus 214 
microscope slides (Fisher Scientific, Pittsburgh, PA, USA). Sections were blocked for 1 215 
h at room temperature with 10% fetal bovine serum in PBS containing 0.5% Triton-X 216 
100 (blocking solution) and then incubated overnight at 4 °C with the primary 217 
antibodies (rabbit anti-R-Ras 1:200, rabbit anti-R-Ras2 1:500, mouse anti-Nkx2.2 1:250 218 
(DSHB Cat# 74.5A5, RRID:AB_531794, Iowa, USA), kindly provided by Aixa 219 
Morales (Cajal Institute, CSIC, Madrid, Spain), rabbit anti-olig2 1:500, rabbit anti-220 
cleaved caspase-3 (Asp175) 1:500 (Cell Signaling Technology Cat# 9661, 221 
RRID:AB_2341188), rabbit anti-MBP 1:300 (Abcam Cat# ab40390, 222 
RRID:AB_1141521), mouse anti-NF200 clone NE14 1:300 (Sigma-Aldrich Cat# 223 
N5389, RRID:AB_260781, St. Louis, Missouri, USA), rabbit anti-Caspr 1:250, mouse 224 
anti-TCF-4 clone 6H5-3 1:200 and mouse anti-O4 1:200 (Millipore Cat# MAB345, 225 
RRID:AB_94872) diluted in blocking solution. After 3 washes, fluorescent-tagged 226 
secondary antibodies were applied for 1 h at room temperature, and sections were 227 
counterstained with DAPI (32670, Sigma-Aldrich, St. Louis, MO, USA) and mounted 228 
in Aqua-polymount mounting medium (Cat#18606; Polyscience; Warrington, PA, 229 
USA).  230 
BrdU injections were administered intraperitoneally to pregnant mice (100 μg/g) at 231 
different stages of embryo development. One hour after BrdU administration, the 232 
mother was euthanized and the brains of embryos were fixed overnight in 4% PFA. 233 
Staining for BrdU was performed as described (Cubelos et al., 2008). Briefly, slides 234 
were incubated overnight at 4 °C with a mouse monoclonal anti-BrdU antibody 1:200 235 
(Becton Dickinson Cat# 347580, RRID: AB_609568, New Jersey, USA). Secondary 236 
Alexa 598-conjugated anti-rat antibodies 1:500 (Molecular Probes, Eugene, Oregon, 237 
USA) were applied for 2 h at room temperature. Anatomically-matched sections were 238 
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selected from each mouse at each stage after BrdU injection (n=3, control mice 239 
and n=3, R-Ras1−/−;R-Ras2−/− mice). Identical results were obtained from independent 240 
analysis by two investigators. Quantification of positive cells was performed always in 241 
the same part of the tissues with ImageJ software (RRID:SCR_003070, Wisconsin-MA, 242 
USA). 243 
Toluidine blue staining. Mice were anesthetized as indicated above, intracardially 244 
perfused with 4% PFA and 2.5% glutaraldehyde in 0.1 M PBS, and brains were 245 
dissected and treated in the same fixative overnight. Sections were made with a Leica 246 
VT1200 S vibrating blade microtome (100 μm), washed 10 min in PBS and stained for 247 
1 min with 200 μl of 0.1% toluidine blue, and finally washed with distilled water and 248 
ethanol for 30 sec. Pictures were taken with a Leica MZ6 magnifying glass for the 249 
proper location of implanted recording electrodes. 250 
Electron microscopy. Mutant and littermate control mice were anesthetized as 251 
indicated above, intracardially perfused with 4% PFA and 2.5% glutaraldehyde in 0.1 M 252 
PBS, and treated in the same fixative overnight. Then, optic nerves were removed after 253 
several washes in PBS, the sections were postfixed with 1% osmium tetroxide in 254 
double-distilled water and 1% potassium ferrocyanide 1 h at 4 ºC. After three washes 255 
with double-distilled water they were treated with 0.15% tannic acid in PBS (0.1 M pH 256 
7.4) and block-stained with 2% uranyl acetate in distilled water for 1 h at room 257 
temperature in darkness. Sections were then washed 3 times with double-distilled water 258 
and dehydrated in an ascending series of ethanol dilutions up to 100% at 4 ºC. The 259 
following infiltration was made with propylene oxide: EtOH (1:1; v:v) for 5 min, 260 
propylene oxide 3 times for 15 min each, propylene oxide:Epon (1:1) (epoxy resin 261 
TAAB 812, TAAB laboratories, Berkshire, England) 45 min, 100% Epon 1 h, 100% 262 
Epon overnight. Encapsulation was made in flat molds where optic nerves were 263 
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correctly oriented and then polymerized 48 h at 60 ºC. Semi-thin (1 μm) sections were 264 
stained with toluidine blue. The optic nerve was cut in 70-80 nm sections on an 265 
ultramicrotome (Leica Ultracut UCT, Wetzlar, Germany) with a diamond blade 266 
(DIATOME) and collected on Cu-Pd boutonniere grids covered by Formvar. Staining 267 
of ultrathin sections was performed by drops of 2% aqueous uranyl acetate for 7 min 268 
followed by Reynolds’s lead citrate for 2 min. Ultrastructural analyses were performed 269 
with a JEM-1010 electron microscope (Jeol, Japan). For g-ratio analysis, twelve 270 
pictures were taken along the section covering the whole diameter of the optic nerve 271 
using a CMOS 4K x 4K, F416 of TVIPS camera (Gauting, Germany). From these 272 
pictures, six in perfect condition that matched the mutant and control, were used to 273 
measure the thickness of the myelin sheath of optic nerve axons by g-ratio analysis (the 274 
diameter of axon / the diameter of axon plus myelin sheath). All axons present in the 275 
entire image were analyzed (around 800-1000 axons per genotype). To quantify the 276 
number of fibers crossing the corpus callosum, pictures were taken in the medial corpus 277 
callosum covering its whole width, and the total number of axons were quantified. 278 
Three animals per genotype were analyzed, and identical results were obtained from 279 
independent analysis by 3 investigators. 280 
Confocal microscopy and imaging. Fluorescence images were obtained using a confocal 281 
multispectral Leica TCS SP8 system (Leica Microsystems) equipped with a white-light 282 
laser for selection of appropriate fluorochrome excitation lines (488 nm and 550 nm), a 283 
405 nm diode for DAPI excitation and HyD detectors for signal emission capture. 284 
Image acquisition was performed sequentially using 20x/0.75 NA dry and 63x/1.4NA 285 
oil immersion objectives with LAS X v. 2.0.1 software (Leica Microsystems). All 286 
images were processed and quantified using Adobe PhotoShop (Adobe Systems, 287 
RRID:SCR_014199, San Jose, CA, USA) and ImageJ. 288 
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Primary cell cultures and staining. OPCs were obtained from cortex and optic nerve of 289 
P1 control and R-Ras1-/-;R-Ras2-/- littermate mice, following an adapted protocol for 290 
OPC isolation by shaking (McCarthy and de Vellis, 1980; Molina-Holgado et al., 2002; 291 
Medina-Rodriguez et al., 2013; Murcia-Belmonte et al., 2014).  292 
Purified OPCs were placed on 12 mm cover glass pre-treated with 10 μg/ml poly-lysine 293 
(#P2636; Sigma-Aldrich; St. Louis, MO, USA) in 0.1 M borate buffer (pH 8.5) and 294 
laminin (L2020; Sigma-Aldrich) the same day of the culture. 20000 cells per well were 295 
cultured in differentiation buffer containing BME (41010; Gibco; Grand Island, New 296 
York, USA), F12 (21765; Gibco), transferrin (T0665; Sigma-Aldrich), putrescin 297 
(P5780; Sigma-Aldrich), progesterone (P6149; Sigma-Aldrich), sodium selenite 298 
(Sigma-Aldrich), insulin (I1882; Sigma-Aldrich), T4 (T1775; Sigma-Aldrich), 299 
glutamine (25030; Gibco), anti-mycotic solution and 0.6% glucose. After 14 days in 300 
vitro (DIV) of differentiation, OLs were fixed with 4% PFA for 20 min and washed. 301 
OLs were placed in PBS containing 0.5% Triton-X 100 for 20 min and then blocking 302 
solution (10% FBS in PBS containing 0.5% Triton-X 100) for 30 min. After that, they 303 
were incubated for 2 h at room temperature with primary antibodies (1:500 dilution of 304 
mouse anti-CNPase, Biolegend, #SMI-91R, RRID: AB_10122287, St. Diego, 305 
California, USA or a 1:250 dilution of rabbit anti-Olig2). After washing, cells were 306 
incubated 35 min with fluorescent-tagged secondary antibodies and DAPI (32670; 307 
Sigma-Aldrich). OLs from three different experiments were classified according to their 308 
morphologies in two different groups (Kremer et al., 2009), one where the number and 309 
complexity of processes was very low (simple processes) and another where the 310 
processes had a high degree of arborization (complex processes). 311 
RT-qPCR. RNA was extracted from optic nerves from control, R-Ras1-/-, R-Ras2-/- and 312 
R-Ras1-/-;R-Ras2-/- mice using an RNeasy kit according to the manufacturer’s 313 
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instructions (Qiagen Cat# 74134; Venlo, Netherlands). RNA was reverse-transcribed 314 
using random hexamers and SuperscriptIII reverse transcriptase (Superscript III First 315 
Strand Synthesis Supermix for qRT-PCR, no amperase UNG, Cat. No. 11752-250, 316 
Thermofisher; Waltham, MA, USA) according to the manufacturer´s instructions. 317 
cDNA was amplified using the BioRadC FX 384 thermocycler and Eva Green Sso Fast 318 
(BioRad, California, USA), Power Sybr Green or Taqman Master Mix. The following 319 
primers were used: For R-Ras1 (R-Ras-FW sense 5´-320 
AAGGCAGATCTGGAGAACCA-3´, R-Ras-RV antisense 5´-321 
TGCCTCATCGACATTCAGAC-3´), for R-Ras2 (R-Ras2-FW sense 5´-322 
CGTGATGAGTTTCCCATGATT-3´, R-Ras2-RV antisense 5´-323 
TAACTGCTGCCCTTCTTCCT-3´). All primers were designed to span at least one 324 
intron. Expression levels were normalized to GAPDH, ActB, HPRT1, 18S, TBP, ARBP 325 
and GUSB expression, and fold-changes were calculated by dividing normalized 326 
expression in control (value 1) by that of R-Ras1-/- or R-Ras2-/-. qPCR data was analyzed 327 
with GenEx Professional 5.3.7 software (MultiD, Sweden). 328 
Electrophysiology. Control (n=9), R-Ras1-/-(n=13), R-Ras2-/- (n=13) and R-Ras1-/-;R-329 
Ras2-/- (n=14) mice were prepared for chronic recording of field potentials evoked at the 330 
lateral geniculate nucleus by stimulus (flashes of light). For this, animals were 331 
anesthetized with 4% chloral hydrate and stereotaxically implanted with two recording 332 
electrodes in the dorsal part of the lateral geniculate nucleus (2.2-2.5 mm posterior to 333 
the bregma, 2.0 mm lateral to the midline and ‒2.5 mm depth from brain surface 334 
(Paxinos and Franklin, 2013). Electrodes were made from 50 μm teflon-coated tungsten 335 
wire (Advent Research Materials, Eynsham, UK). Two bare silver wires were affixed to 336 
the skull as ground. Electrodes were connected to a 4-pin socket (RS-Amidata, Madrid, 337 
Spain) that was latterly fixed with dental cement to the cranial bone. After surgery, 338 
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animals were kept for 5 days in independent cages with free access to food and water 339 
for a proper recovery. Light stimulation was provided by a xenon arc lamp located 30 340 
cm in front of the animals’ eyes and lasted ~1 ms (Photic stimulator, Cibertec, Madrid, 341 
Spain). For recordings, each alert behaving mouse was placed in a transparent box (5 ? 342 
5 ? 5 cm), dark-adapted for >30 min and presented with a total of 20 stimuli at a rate of 343 
3 per min. This box was in the center of a larger (30 ? 30 ? 30 cm) covered by polished 344 
aluminum walls. Photic stimulations were triggered from a programmable CS-20 345 
stimulator (Cibertec). Each animal received two stimulation sessions. 346 
Statistical Analysis. Quantitative data are presented as the mean ± standard deviation 347 
(SD). The experimental groups were compared using a two-tailed Student´s t-test. 348 
Statistical numeric data are provided in the legends. (*) means p<0.05; (**) means 349 
p<0.01; (***) means p<0.001.  350 
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Results 351 
R-Ras1 and R-Ras2 are expressed by oligodendrocytes in myelinated CNS tracts 352 
While OLs may express R-Ras1 (Olsen and Ffrench-Constant, 2005), the distribution of 375 
R-Ras2 remains undetermined. So, we precisely defined the expression of R-Ras1 and 376 
R-Ras2 in different myelinated areas of the CNS in adult mice (P90). Using 377 
immunoblotting, we probed samples from the main myelinated tracts of the CNS for R-378 
Ras1 and R-Ras2, including: the optic nerve (which consists almost entirely of 379 
myelinated axons) (Fig. 1A), corpus callosum (Fig. 1B) and spinal cord (Fig. 1C). Given 380 
the strong homology between R-Ras1 and R-Ras2, antibodies against these GTPases 381 
recognize both proteins. We can easily detect two bands of different molecular weights 382 
in Western blots: a 25 kDa band corresponding to R-Ras1 (Iwasawa et al., 2012) and a 383 
21 kDa band corresponding to R-Ras2 (Delgado et al., 2009). In double null mutant 384 
mice lacking both R-Ras1 and R-Ras2, no immunoreactivity was observed, confirming 385 
the antibodies used are specific for R-Ras1 and R-Ras2 (Fig. 1A-C). We could 386 
unequivocally confirm the absence of the appropriate proteins in the single null mutants 387 
(Fig. 1A). R-Ras3 expression was not modified in R-Ras1-/- and/or R-Ras2-/- mice, 388 
showing a band of 24 kDa (Fig. 1A-C). 389 
To generate R-Ras1 deletion mutants, we used a germ-line knockout mouse with exons 390 
2-6 deleted, the region that encodes most of the protein (Fig. 1D). We genotyped mice 391 
by PCR using primers 1 and 2 to detect the alleles corresponding to R-Ras1+/+ mice and 392 
a mixture of primers 3 and 4 to identify the R-Ras1-/- mutants (Fig. 1E). We also used a 393 
R-Ras2 knockout mouse line produced from an embryonic stem cell clone with a 394 
retroviral insert in the first intron of R-Ras2 (Delgado et al., 2009) (Fig. 1F). Finally, we 395 
generated R-Ras1/R-Ras2 double null mutant mice by backcrossing the individual R-396 
Ras1-/- and R-Ras2-/- lines. These mice were backcrossed for ten generations onto the 397 
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C57BL/6J strain to exclude any distortions induced by background variations. 398 
Quantitative PCR and immunoblot analysis of the CNS confirmed the absence of 399 
expression of these genes in R-Ras1-/-, R-Ras2-/- and double-mutant mice (Fig. 400 
1A,B,C,G). 401 
We then determined whether OLs express R-Ras1 and R-Ras2 using double 402 
immunohistochemical staining with antibodies against R-Ras1/R-Ras2 and Nkx2.2, a 403 
homeobox transcription factor expressed by oligodendroglial cells (Qi et al., 2001). In 404 
longitudinal sections of the optic nerve from adult mice (P90), both R-Ras1 and R-Ras2 405 
co-localized with Nkx2.2 (Fig. 1H), which was also observed in the corpus callosum 406 
and spinal cord (data not shown). So, we conclude that R-Ras1 and R-Ras2 are 407 
expressed in OLs of the main myelinated CNS tracts. 408 
Oligodendrocyte population is diminished in R-Ras1-/-, R-Ras2-/- and R-Ras1-/-;R-409 
Ras2-/- mice  410 
To study whether the absence of R-Ras1 and/or R-Ras2 altered oligodendroglial cells, 411 
we utilized immunohistochemical staining of optic nerves with the oligodendroglial-412 
specific Olig2 antibody in longitudinal sections from R-Ras1-/-, R-Ras2-/-  and double-413 
mutant adult (P90) mice (Fig. 2A,B). Histological examination revealed a decrease in 414 
oligodendroglial cell density in R-Ras1-/- (19.1±7.5% reduction; p=0.02), R-Ras2-/- 415 
(33.5±2.1% reduction; p<0.0001) and R-Ras1-/-;R-Ras2-/- (42.8±11.8% reduction; 416 
p=0.003) mice compared to controls (Fig. 2A,C). The reduction in oligodendroglial cells 417 
was more pronounced in double mutants (p=0.02) followed by R-Ras2-/- (p=0.003) 418 
compared with R-Ras1-/- (Fig. 2C). We examined whether R-Ras1 and R-Ras2 were 419 
essential to maintain the OL population in other myelinated CNS tracts and confirmed 420 
the reduction in oligodendroglial population in the double-mutant mice compared to 421 
controls (38±15.6% reduction in the corpus callosum, p<0.0001; and 27±6.1% reduction 422 
 18 
in the spinal cord, p=0.007; data not shown). These observations demonstrate that R-423 
Ras1 and R-Ras2 jointly maintain the OL populations in the main myelinated CNS 424 
tracts. 425 
Absence of R-Ras1 and R-Ras2 reduces activation of PI3K/Akt and Erk1/2-MAPK 426 
signaling pathways  427 
Given that R-Ras1 and R-Ras2 can activate PI3K/Akt signaling (McFall et al., 2001; 428 
Rosario et al., 2001; Murphy et al., 2002; Rong et al., 2002; Delgado et al., 2009) and 429 
Erk1/2-MAPK (Graham et al., 1994; Movilla et al., 1999; Rosario et al., 1999), we 430 
examined these pathways in the optic nerve of P90 mice by Western blot using 431 
antibodies against phosphorylated Akt and Erk (active versions)(Fig. 3A). We found a 432 
reduction of both Akt phosphoepitopes T308 and S473 in single and double mutants 433 
(Fig. 3A), indicating a decrease in PI3K/Akt activity in R-Ras1- and R-Ras2-deficient 434 
adult (P90) mice. We then analyzed S6K activity, a kinase that regulates mTOR, by 435 
measuring S6 phosphorylation levels. We confirmed a significant decrease in the 436 
activity of the PI3K/Akt pathway in the absence of R-Ras1 and/or R-Ras2, with no 437 
change in the total levels of these proteins (Fig. 3A). We also examined activity of the 438 
Erk1/2-MAPK pathway in our mutant mice, observing a reduction in Erk1/2 439 
phosphorylation in the single- and double-mutant mice relative to the controls. We 440 
found that activation of the PI3K/Akt and Erk1/2-MAPK pathways was weaker in mice 441 
lacking one or both of these GTPases, which suggests that both proteins coordinate the 442 
activity of these two pathways (Fig. 3B).   443 
Using immunohistochemical staining for Olig2 at different stages of OPC 444 
differentiation (E12.5, E14.5, P0, P15), we did not detect differences in 445 
oligodendrogenesis between double-mutant and control mice. The Olig2 446 
immunostaining suggested that normal oligodendrocyte migration occurs in double-447 
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mutant mice, as OPCs born at E12.5 and E15.5 normally colonized the optic nerve and 448 
corpus callosum tracts (data not shown), as previously reported (Spassky et al., 2002; de 449 
Castro F., 2013). We also evaluated OL proliferation using BrdU labelling at different 450 
developmental stages (E14.5, E18.5, P0 and P15), finding no differences between 451 
double-mutant and control mice (data not shown). These experiments show that the 452 
absence of R-Ras1 and/or R-Ras2 does not affect OPC genesis, migration or 453 
proliferation, and rather that R-Ras1 and R-Ras2 contribute to postmitotic 454 
oligodendroglia differentiation to form mature OLs. 455 
Next, we analyzed whether decreased activation of the PI3K/Akt and Erk1/2-MAPK 456 
pathways affected OL survival. We assessed the number of apoptotic cells in the optic 457 
nerve and corpus callosum with an antibody against active/cleaved caspase-3 in double-458 
mutant and control mice. Quantification of caspase-3-positive cells in the optic nerve at 459 
P30 showed increased apoptosis in double-mutant relative to control mice (45.28±17.39 460 
cells/mm2 in double-mutants and 11.13±8 cells/mm2 in control mice: p=0.012. Fig. 461 
3C,D). So, dampened Erk1/2-MAPK and/or PI3K/Akt signaling may diminish cell 462 
survival, producing fewer OLs in R-Ras1- and R-Ras2-deficient mice. 463 
Expression of typical myelin proteins is also reduced in R-Ras1-/-, R-Ras2-/- and R-464 
Ras1-/-; R-Ras2-/- double-mutant mice 465 
Given that OLs are the only cell type responsible for myelin production in the CNS, we 466 
wanted to determine how the reduced OL populations affected the amount of myelin 467 
sheathing the axons of mutant mice. We conducted a histological analysis using coronal 468 
sections of the adult brain (P90) and discovered a decrease in the corpus callosum in 469 
double-mutant mice compared to controls (Fig. 4A). Quantification revealed a decrease 470 
in average corpus callosum thickness in R-Ras1-/-;R-Ras2-/- (168±11.5 ?m) compared to 471 
controls (360±44.5, p<0.0001; Fig. 4B). Since we found no significant reduction in the 472 
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number of axons forming this tract (3705±943 axons in control mice and 4377±1137 473 
axons in R-Ras1-/-;R-Ras2-/-), its reduced size could reflect a deficit in the amount of 474 
myelin in these double-mutant mice. We then examined the corpus callosum and optic 475 
nerve from adult (P90) mice using immunohistological staining with specific antibodies 476 
against the myelin marker protein MBP (myelin basic protein). We saw a dramatic 477 
reduction in the amount of myelin enveloping axons in double-mutant mice compared 478 
to controls (Fig. 4 C,D). 479 
We confirmed the decrease in myelin from adult (P90) optic nerve homogenates by 480 
Western blots using antibodies against MBP and myelin-associated glycoprotein 481 
(MAG) from adult mice lacking R-Ras1 and/or R-Ras2 and controls (Fig. 4E). 482 
Specifically, levels of MAG and MBP protein were lower in single and double mutants 483 
compared to control mice (MAG: R-Ras1-/-=27.12±13.28% reduction, p=0.008; R-Ras2-484 
/-=36.35±9.45% reduction, p=0.00263; and the double mutant=47.18±13.19% reduction, 485 
p=0.00345. MBP: R-Ras1-/-=30.76±18.40% reduction, p=0.0057; R-Ras2-/-486 
=43.64±20.53% reduction, p=0.00144; and R-Ras1-/-;R-Ras2-/-=56.53±19.03% 487 
reduction, p=0.00016 (Fig. 4G). In addition, expression of MAG and MBP in the corpus 488 
callosum (Fig. 4E) and spinal cord (data not shown) confirmed that the levels of myelin 489 
were reduced dramatically in the major myelinated CNS tracts in the absence of R-Ras1 490 
and R-Ras2 (MAG R-Ras1-/-;R-Ras2-/- 27.52±15.91% reduction, p=0.004; MBP R-Ras1-491 
/-;R-Ras2-/- 55.48±20.53% reduction, p<0.0001, Fig. 4F).   492 
Myelin sheath thickness is reduced in R-Ras1-/-, R-Ras2-/- and R-Ras1-/-;R-Ras2-/- 493 
mice 494 
To further examine the ultrastructure of myelin tracts, we analyzed the optic nerves 495 
from R-Ras1-/-, R-Ras2-/-, double-mutant and control adult mice (P90) with electron 496 
microscopy (EM). We found that the myelin sheath was thinner in single and double 497 
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mutants compared to controls (Fig. 5A). Morphometric quantification of the g-ratios for 498 
individual fibers compared to the respective axon diameter in the optic nerve (presented 499 
as scatter plots) confirmed the reduction in myelin sheath thickness in R-Ras1-/- and R-500 
Ras2-/- mice that was more pronounced in double-mutant compared to control mice (Fig. 501 
5C). Specifically, we quantified significant increases in the mean value of the g-ratio of 502 
single (R-Ras1-/-=0.87±0.04, p<0.0001, and R-Ras2-/-=0.8±0.08, p<0.0001) and double-503 
mutant mice (R-Ras1-/-;R-Ras2-/-=0.89±0.06, p<0.0001) compared to controls 504 
(0.75±0.09). 505 
To check whether there was a change in the axonal diameter of double mutants 506 
compared with the controls, we classified the axons according to their diameter (Fig. 507 
5F). The double mutants showed an increase in the number of axons of lower caliber 508 
associated with a decrease in axons of greater diameter (R-Ras1-/-;R-Ras2-/- = 42% 509 
increase in axons <400 nm, p<0.0001 and 29% reduction in axons >1000 nm, 510 
p=0.0002).  511 
Regardless of axon caliber, we found a clear thinning of the myelin sheath in single (R-512 
Ras1-/- =105±53 nm, p<0.0001; R-Ras2-/-=159±75 nm, p<0.0001) and double mutants 513 
(R-Ras1-/-;R-Ras2-/-=73±40 nm, p=0.0001) relative to controls (251±60 nm) (Fig. 5E). 514 
We quantified the number of axons that were myelinated, finding that in the absence of 515 
R-Ras1 there was a decrease in the amount of myelin (Fig. 4E,G, 5A,B,C,E)  without 516 
changes in the number of myelinated axons (Fig. 5D)  which indicates that these axons 517 
were covered by a thinner myelin sheath. However, the absence of R-Ras2 produced a 518 
30% reduction in the number of myelinated axons concurrent with a loss of myelin. The 519 
most drastic phenotype was presented by the double mutant, in which there was a 75% 520 
decrease in number of myelinated axons. In addition, these mice R-Ras1-/-;R-Ras2-/- 521 
show a great decrease in the amount of myelin, this indicates that these axons are coated 522 
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by a very thin myelin sheath, raising the value of the g-ratio. These results demonstrate 523 
the hypomyelination of the optic nerve in mice lacking R-Ras1 and/or R-Ras2. The 524 
phenotype of the double mutant corresponds to the sum of the defects observed in the 525 
single mutants. 526 
We then analyzed the structure, degree and periodicity of compaction of the myelin 527 
sheaths at a higher magnification and found no differences among mutant and control 528 
mice (Fig. 5A,B). However, there were clearly fewer turns in the myelin sheaths from 529 
single mutants and even fewer in double mutants (Fig. 5B). Thus, we conclude that the 530 
reduced myelin thickness arises from fewer myelin layers. The phenotype of the double 531 
mutant indicates that R-Ras1 and R-Ras2 play additive roles in myelination. 532 
R-Ras1 and R-Ras2 are necessary for proper oligodendrocyte differentiation 533 
To evaluate whether the observed myelin loss arose from altered OPC differentiation 534 
into mature OLs, we stained brain sections from mice at the most active stages of 535 
myelination in vivo (P15). The antibody used was against O4 (a sulfatide and pro-536 
oligodendroblast antigen), which is a marker for cell bodies and processes from late 537 
precursors and  immature pre-myelinating OLs (Sommer and Schachner, 1981; Dawson 538 
et al., 2000; Woodruff et al., 2001; Ramos et al., 2011). We found increased intensity in 539 
O4-labeling in the corpus callosum, which suggests an alteration in the degree of OL 540 
differentiation in double mutants compared to controls (Fig. 6A,B). We then performed 541 
dual immunohistochemistry with anti-Tcf4, a specific marker of pre-myelinating 542 
immature OLs (Emery, 2010), and anti-Olig2, which recognizes the complete 543 
oligodendrocytic lineage. We found a significant increase in the population of immature 544 
OLs (Tcf4+) in double-mutant compared to P15 control mice (Fig. 6C). The proportion 545 
of immature OLs (Tcf4+) relative to the total OL population (Olig2+) almost doubled in 546 
R-Ras1-/;R-Ras2-/- mutants relative to control mice (100±7% for controls and 191±39% 547 
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for R-Ras1-/-;R-Ras2-/-, p=0.016; Fig. 6C,D). We observed that the increase in Tcf4 was 548 
maintained at P30 (100±20% for controls and 255±14% for R-Ras1-/-;R-Ras2-/-, 549 
p=0.002; Fig. 6D) and at P120 (100±27% for controls and 170±53% for R-Ras1-/-;R-550 
Ras2-/-, p=0.017; Fig. 6D).  We found a significant increase in the population of 551 
immature OLs, not only in early postnatal stages (P15 and P30) but also in adult mice 552 
(P120). Besides, double immunohistochemical staining in adult mice (P120) with anti-553 
Olig2 and anti-CC1, a marker of mature OLs, showed, as expected, a significant 554 
reduction in the proportion of mature OLs in the double mutant (35.8± 8.6% CC1/Olig2 555 
positive cells) compared with the control (83.8±0.9% CC1/Olig2 positive cells, 556 
p=0.0006, Fig. 6 E,F). Therefore R-Ras1 and R-Ras2 seem to be necessary for the 557 
adequate maturation of OLs. 558 
To test whether the lack of R-Ras1 and R-Ras2 dampened OL maturation, we prepared 559 
enriched OL cultures from the cortex and optic nerve of newborn R-Ras1-/-;R-Ras2-/- 560 
mice and their control littermates. We found that by 14 DIV, OLs from the double-561 
mutant mice expressed CNPase and formed a more simplified network of processes 562 
than those from control mice, suggesting that OL maturation is affected by loss of R-563 
Ras1 and R-Ras2 (Fig. 6G). After labeling with anti-CNPase and anti-Olig2 antibodies, 564 
we classified OL morphology as having either simple (primary and secondary) or 565 
complex (tertiary or myelin network) processes to reflect the changes associated with 566 
OL differentiation. This quantification of cell morphology (introduced by Kremer et al., 567 
2009) revealed distinct differences in OL maturation between R-Ras1-/-;R-Ras2-/- and 568 
control mice. OLs from R-Ras1- and R-Ras2-deficient mice had more simple processes 569 
than control mice at the expense of complex processes (45.7±12.69% increase for R-570 
Ras1-/-;R-Ras2-/- relative to the control, p=0.0106; Fig. 6H). So, we conclude that OLs in 571 
double-mutant mice acquire a simpler morphology with less complex networks of 572 
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processes, indicating that R-Ras1 and R-Ras2 are essential for proper morphological 573 
differentiation in vitro. 574 
 R-Ras1 and R-Ras2 modify the size of the nodes of Ranvier and axon conduction 575 
velocity in the optic nerve 576 
Myelin sheathes axons in segments separated by nodes of Ranvier, which are short and 577 
periodic interruptions in the myelin sheath (Fig. 7B). Given the observed 578 
hypomyelination in the optic nerve and corpus callosum of the double-mutant mice, we 579 
analyzed the gross structure of the nodal region by immunostaining against a protein 580 
located in the paranodal region, Caspr (Kamasawa et al., 2005; Murcia-Belmonte et al., 581 
2016). Confocal microscopy of longitudinal sections of the optic nerves from adult mice 582 
(P90) immunostained with an antibody against Caspr revealed more paranodal regions 583 
in the double-mutant mice than controls (80.85±19.71 paranodes/67x67μm for the 584 
double mutant and 54.09±14.22 paranodes/67x67μm for the control, p=0.000124; Fig. 585 
7A,E). Indeed, we detected more Caspr protein in the adult (P90) double mutants 586 
relative to control mice after probing immunoblots of optic nerve homogenates for 587 
Caspr (p=0.016; Fig. 7C). The paranodal increase in the double mutant indicates a 588 
shorter internodal length, generating shorter myelin sheaths compared with controls 589 
(Savvaki et al., 2008) (Fig. 7D). Altered myelination may also correlate with aberrant 590 
nodal and paranodal structures (Savvaki et al., 2008; Tanaka et al., 2009; Lee et al., 591 
2011; Murcia-Belmonte et al., 2016). After classification of the different nodes and 592 
paranodes according to their length, we did not detect differences in paranode length 593 
(Fig. 7F). In contrast, we revealed a dramatic increase in the proportion of shorter nodes 594 
(less than 0.5 microns) in R-Ras1-/-;R-Ras2-/- mice relative to controls (30±4.5% for 595 
double mutant and 7.4±5.1% for controls, p=0.004; Fig. 7A boxed insert, G). 596 
Accordingly, these double-mutant mice had fewer long nodes (between 1 and 1.5 597 
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microns: 6.95±4.05% for R-Ras1-/-;R-Ras2-/- and 25.65±6.05% for control mice, 598 
p=0.011; Fig. 7A boxed insert, G). As the number of nodes of Ranvier and internodes 599 
increased, they became closer together (a decrease of approx. 15% in length) in the 600 
absence of R-Ras1 and R-Ras2. 601 
The decreased myelin sheath thickness and the presence of shorter nodes could provoke 602 
abnormal conduction of nerve impulses in the major CNS myelinated tracts (Richardson 603 
et al., 2000; Bakiri et al., 2011). Thus, we measured the conduction velocity of nerve 604 
impulses along the optic nerve in vivo. We implanted recording electrodes into the 605 
dorsal part of the lateral geniculate nucleus of our four groups of mice (Fig. 8A-C) and 606 
stimulated the animals bilaterally with light flashes. As previously described (Wiggins 607 
et al., 1982; Meeren et al., 1998), flash stimulation evokes an early positive-negative-608 
positive field potential followed by some late oscillatory components. The early positive 609 
component (P1, Fig. 8C) presented latencies similar for the four groups of adult mice 610 
(P120) (9.58±1.09 ms for controls; 9.73±1.67 ms for R-Ras1-/-, p=0.542; 10.32±2.38 ms 611 
for R-Ras2-/-, p= 0.945; and 9.77±1.35 ms for R-Ras1-/-;R-Ras2-/-, p=0.715; Fig. 8D), 612 
which confirmed the presence of unaffected axons in the optic nerve (see above). These 613 
latencies were in the range of unitary activation of ganglion cells by photic stimulation 614 
in mice (Lintas et al., 2013). The negative component of the evoked field potential 615 
presented successive downward sags and a total long duration in mutant mice compared 616 
to controls (Fig. 8C). These successive negative waves suggest a delayed depolarization 617 
of geniculate neurons from arriving ganglion axon terminals. Indeed, a quantitative 618 
analysis of the latency of visually evoked potentials showed a significant increase in 619 
their latency in single and double mutant mice relative to control mice (19.19±2.90 ms 620 
for controls; 23.08±1.51 ms for R-Ras1-/-, p=0.00081; 24.51±2.71 ms for R-Ras2-/-, p= 621 
0.000385; and 26.36±2.22 ms for R-Ras1-/-;R-Ras2-/-, p=0.0000022; Fig. 8E). Although 622 
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we found alterations in conduction velocity in the two single mutant mice, we found the 623 
most dramatic differences in the double mutant. These results strongly suggesting that 624 
R-Ras1 and R-Ras2 have cooperative and non-redundant functions. Consequently, our 625 
observed structural and electrophysiological alterations reveal that R-Ras1 and R-Ras2 626 
are essential to achieve the correct velocity for nerve impulse conduction in myelinated 627 
CNS tracts. 628 
  629 
 27 
Discussion  630 
Here we provide in vivo evidence that R-Ras1 and R-Ras2 play an essential role in 631 
regulation of myelination by controlling fundamental parameters of OL survival and 632 
differentiation. Our data demonstrate that mice lacking R-Ras1 and/or R-Ras2 showed 633 
hypomyelination in major CNS tracts, reducing the conduction velocity of nerve 634 
impulse through them. 635 
Loss of either R-Ras1 or R-Ras2 reduced the number of OLs, but a more dramatic 636 
reduction occurred with the loss of both. Hence, R-Ras1 and R-Ras2 may cooperatively 637 
maintain the OL population. As the double mutant induced the most severe phenotype, 638 
R-Ras1 and R-Ras2 do not seem functionally redundant and cannot compensate for 639 
each other. We acknowledge that the classical Ras members were not modified and did 640 
not compensate for the loss of R-Ras (data not shown). 641 
We also detected clear differences in OL differentiation and maturation in these mutant 642 
mice. Indeed, our double-mutant mice more strongly expressed markers of 643 
premyelinating OLs, associated with lower expression of markers of maturity. OPCs 644 
undergo stereotyped morphological changes as they differentiate (Kremer et al., 2009). 645 
Specifically, oligodendroglial cells in dissociated cultures extend cell processes until 646 
they acquire a truly branched morphology (Ishii et al., 2012; Zuchero et al., 2015). We 647 
found that R-Ras1- and R-Ras2-deficient OLs formed a simpler network of processes 648 
than control OLs, suggesting that loss of R-Ras1 and R-Ras2 alters oligodendrocyte 649 
maturation in vitro and in vivo. 650 
Defects in OL differentiation and maturation hinder myelination (Wolswijk, 1998; 651 
Kuhlmann et al., 2008; Kremer et al., 2011). When we quantified essential myelin 652 
proteins in the optic nerve and corpus callosum, we discovered distinct hypomyelination 653 
in the absence of R-Ras1 and R-Ras2. Specifically, MAG and MBP expression 654 
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gradually decreased in these mutants, while a more significant decrease was evident in 655 
the double mutants. Electron microscopy analysis of transverse optic nerve sections 656 
from adult mice (P90) illustrated how axons possessed thinner myelin sheaths, 657 
regardless of axon diameter. R-Ras1-/- and R-Ras2-/- showed different g-ratio profiles, 658 
which could suggest a specific role for each of these GTPases in specific subpopulations 659 
of OLs. While we found a gradual decrease in myelin sheath thickness in single 660 
mutants, this decrease was more dramatic in the absence of both R-Ras1 and R-Ras2. 661 
Despite the dramatic decrease in axonal myelin thickness in our mutants, we observed 662 
no alterations in the degree of sheath compaction. These results suggest that the 663 
mechanism responsible for assembling myelin sheaths around axons is independent of 664 
R-Ras1 and R-Ras2.  665 
The decrease in myelin production in the absence of R-Ras1 and R-Ras2 was much 666 
more drastic than the loss of OLs. This result indicates that the surviving OLs are 667 
immature and incapable of myelinating axons correctly. We discovered distinct myelin 668 
deficiency in axons of all calibers, although not all fibers had hypomyelination. We 669 
propose that CNS axons can differ in their proclivity to acquire a myelin sheath, as 670 
suggested by (Nave and Werner, 2014). Although axon diameter was comparable 671 
between mutant and control mice, we noted a tendency towards a reduced axon caliber 672 
in mutants lacking R-Ras1 and/or R-Ras2, consistent with findings that OLs condition 673 
axon caliber (Hildebrand and Hahn, 1978; de Waegh et al., 1992; Hildebrand et al., 674 
1993; Sanchez et al., 1996; Goebbels et al., 2010). Myelination may require 675 
communication between axons, astrocytes and OLs to determine myelin sheath 676 
thickness (Camargo et al., 2017). However, the contributions of each cell type to sheath 677 
thickness remains unknown. The absence of R-Ras1 and R-Ras2 in neuron-free cultures 678 
suggests an essential role for these GTPases in OPC differentiation. This hypothesis 679 
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accounts for our observed alterations in myelination. We note that the influence of R-680 
Ras1 and R-Ras2 on neurons and/or astrocytes was not explored in detail in our current 681 
study. 682 
Thus, downregulation of the PI3K/Akt and Erk1/2-MAPK pathways could induce 683 
hypomyelination, smaller OL population, diminished cell survival and increased 684 
proportion of immature OLs in the absence of R-Ras1 and R-Ras2. Increased activity of 685 
the PI3K/Akt pathway, either by inhibiting PTEN or constitutively activating Akt in 686 
OLs, does produce hypermyelination without altering OPC proliferation or the final 687 
number of mature OLs (Flores et al., 2008; Goebbels et al., 2010). Moreover, altered 688 
PI3K/Akt signaling affects OL differentiation. Specifically, inhibition of mTOR, an 689 
effector of this pathway, blocks OL differentiation and preserves them in a 690 
premyelinating state associated with no myelin production (Tyler et al., 2009; Gaesser, 691 
2016). Likewise, overactivation of the Erk1/2-MAPK pathway in OLs provokes 692 
hypermyelination in major CNS tracts (Ishii et al., 2013). Conversely, loss of Erk1/2 in 693 
mature OLs decreases the amount of myelin with a concomitant reduction in the size of 694 
OL population due to poor OL viability (Ishii et al., 2014). The phenotype we described 695 
in R-Ras1- and R-Ras2-deficient mice could result from a combined effect of de-696 
activation of both the PI3K/Akt and Erk1/2-MAPK pathways. The relationship between 697 
R-Ras1 and R-Ras2 to PI3K/Akt and Erk1/2-MAPK signaling activation must be 698 
addressed in future studies. However, we do propose that R-Ras1 and R-Ras2 are 699 
upstream effectors of both pathways and adequately orchestrate their signaling to 700 
maintain not only survival but also correct OL differentiation. 701 
Efficacy of neural transmission occurs through specific variables, such as myelin 702 
thickness or node and internode length (Waxman, 1980, 1997; Zimmermann and Dours-703 
Zimmermann, 2008; Bekku et al., 2010). Hypomyelination correlates with slower 704 
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conduction velocities, as described in other mouse models that overexpress or lack 705 
distinct myelin proteins (Robaglia-Schlupp et al., 2002; Michailov et al., 2004; Lee et 706 
al., 2011). Some studies suggest weaker myelination yields slower nerve conduction 707 
velocities and abnormal node or paranode structures (Tanaka et al., 2009; Lee et al., 708 
2011). A decrease in newly generated OLs may change myelin structures and induce a 709 
progressive decrease in axonal conduction velocity in the corpus callosum (Schneider et 710 
al., 2016). Our data demonstrate that in the absence of R-Ras1 and R-Ras2, shortening 711 
of the nodes of Ranvier and internodes accompanies hypomyelination, which may cause 712 
the reduced conduction velocity we observed in the optic tract. However, we cannot 713 
exclude that the absence of R-Ras1 and R-Ras2 affects other factors like ion channel 714 
distribution or other structural proteins in the nodal or paranodal regions. This remains 715 
an area for future studies. 716 
To-date, R-Ras1 and R-Ras2 activity in leukodystrophias has not been explored. The 717 
accepted animal model for multiple sclerosis, experimental autoimmune 718 
encephalomyelitis (EAE), is attenuated in R-Ras1-/- because of an increase in 719 
tolerogenic dendritic cells and natural regulatory T cells (Ray et al., 2014). After our 720 
current results, we strongly suggest that the roles of R-Ras1 and R-Ras2 in 721 
demyelinating diseases should be carefully studied, especially the neuropathological 722 
aspects of disease.  723 
In summary, we identified R-Ras1 and R-Ras2 as key elements for OL survival and 724 
differentiation, acting through the synergistic activation of the PI3K/Akt and Erk1/2 725 
signaling pathways. These results are separable from the classical Ras proteins, as they 726 
were neither modified nor compensated for the lack of R-Ras responsivity. Therefore, 727 
we conclude that R-Ras1 and R-Ras2 GTPases are necessary for proper OL-mediated 728 
myelination and regulation of correct nerve impulse transmission. 729 
730 
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Figure legends 731 
Figure 1. OLs express R-Ras1 and R-Ras2 in the main myelinated tracts of the CNS. A, 732 
Immunoblot of adult optic nerve lysates show R-Ras1, R-Ras2 and R-Ras3 expression. 733 
Two different antibodies against R-Ras1 or R-Ras2 recognized both proteins, a band of 734 
25 kDa corresponding to R-Ras1 and another of 21 kDa corresponding to R-Ras2. No 735 
bands were observed in optic nerve lysates from R-Ras1-/-;R-Ras2-/- mice. R-Ras3 736 
expression was not modified in R-Ras1-/- and/or R-Ras2-/- showing a band of 24 kDa. 737 
(n=3). B-C, Western blot of corpus callosum (B) and spinal cord (C) extracts from 738 
control mice confirmed expression of R-Ras1, R-Ras2 and R-Ras3 in primary CNS 739 
myelinated tracts. (n=3). D, Schematic representation of the targeting strategy to 740 
generate the R-Ras1 null mutant. A Neo cassette flanked by FRT sites was inserted into 741 
intron 1 together with two loxP sites flanking exons 2 and 6. The position of the primers 742 
designed for genotyping are shown by the arrows. E, PCR genotyping. A mixture of 743 
primer 1 and primer 2 detected the R-Ras1+/+ (~100 bp) allele by PCR and a mixture of 744 
primer 3 and primer 4 detected the R-Ras1-/- target allele (~1000 bp). F, Generation of 745 
R-Ras2-/- mice. Illustration of the retroviral insertion site of the R-Ras2 gene in intron 1 746 
and the positions of the three primers used for genotyping. G, Analysis of the relative 747 
expression of R-Ras1 and R-Ras2 by RT-qPCR in control, R-Ras1-/-, R-Ras2-/- and R-748 
Ras1-/-;R-Ras2-/- adult mice normalizing all data to control mice. Values expressed as 749 
the mean fold-change of 3 different animals, p<0.0001. H, Longitudinal optic nerve 750 
sections from control, R-Ras1-/-, R-Ras2-/- and R-Ras1-/-;R-Ras2-/- adult mice showing 751 
co-localization between R-Ras1 (top) and R-Ras2 (bottom, green) with Nkx2.2, an 752 
oligodendroglial cell marker (red). No staining for R-Ras1 or R-Ras2 was observed in 753 
the double-mutant mice. (n=3). All samples were obtained from adult mice (P90). Scale 754 
bar: 25μm. 755 
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Figure 2. OL population is significantly diminished in R-Ras1-/-, R-Ras2-/- and R-Ras1-/-756 
;R-Ras2-/- mice. A, Immunolabeling with anti-Olig2 (green) of longitudinal optic nerve 757 
sections from control, R-Ras1-/-, R-Ras2-/- and R-Ras1-/-;R-Ras2-/- adult mice (P90), 758 
show a reduction in the OL population in the mutant mice compared with the controls. 759 
B, Simplified scheme of the visual tract shows the region of analysis. C, Quantification 760 
of the density of Olig2-positive cells per mm2 shows a 19.1±7.5% decrease in R-Ras1-/- 761 
(p=0.02), a 33.5±2.1% reduction in R-Ras2-/- (p<0.0001) and a 42.8±11.8% reduction 762 
(p=0.003) in R-Ras1-/-;R-Ras2-/- mice relative to controls. Reduction of OLs in the R-763 
Ras1-/- mutant mice was significantly less than that observed in the R-Ras2-/- (p=0.003) 764 
and R-Ras1-/-;R-Ras2-/- (p=0.02) mutant mice. The bar graph represents the mean and 765 
SD for the number of Olig2-positive cells per mm2 from six different experiments 766 
(n=6). Scale Bars: 75 μm. 767 
Figure 3. R-Ras1 and R-Ras2 are necessary for OL survival driven by PI3K/Akt and 768 
Erk1/2-MAPK signaling. A, Western blot analysis of phospho-Akt (T308), phospho-769 
Akt (S473) and phospho-S6 in optic nerve lysates of adult mice (P90) shows the 770 
PI3K/Akt pathway was altered in the absence of R-Ras1 and/or R-Ras2. Phosphorylated 771 
proteins were significantly reduced in mutant mice compared to controls. (Bottom) 772 
Western blot analysis shows decreased phosphorylated Erk1/2 (T202/Y204) in adult 773 
optic nerve lysates from R-Ras1-/-, R-Ras2-/- and R-Ras1-/-;R-Ras2-/- mice compared to 774 
controls. Graphs show densitometric analysis of phosphorylated Akt, S6 and Erk1/2 775 
normalized to total protein levels compared to controls (100%, n=4): P-Akt (T308) R-776 
Ras1-/- 78.5±6.51% reduction (p<0.0001), R-Ras2-/- 35.3±12.80% reduction (p=0.0035), 777 
R-Ras1-/-;R-Ras2-/- 34.5±15.23% reduction (p=0.007); P-Akt (S473) R-Ras1-/- 778 
49.2±1.20% reduction (p<0.0001), R-Ras2-/- 53.2±15.92% reduction (p=0.0044), R-779 
Ras1-/-;R-Ras2-/- 62.9±4.92% reduction (p=0.0001); p-S6 R-Ras1-/- 62.6±6.8% reduction 780 
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(p<0.0001), R-Ras2-/- 50.9±15.2% reduction (p=0.0002), R-Ras1-/-;R-Ras2-/- 781 
65.2±23.5% reduction (p=0.0005); p-Erk1/2 R-Ras1-/- 45.4±25.8% reduction (p=0.004), 782 
R-Ras2-/- 55.6±15.3% reduction (p<0.0001),  R-Ras1-/-;R-Ras2-/- 68.5±20.3% reduction 783 
(p<0.0001). B, Schematic representation of the pathways downstream of R-Ras1 and R-784 
Ras2. Discontinuous lines imply indirect activation or inhibition. C, Bar graph shows 785 
the mean number of caspase-3-positive cells per mm2 observed in P30 optic nerves from 786 
R-Ras1-/-;R-Ras2-/- (45.28±17.39) compared with controls (11.14±8.01, p=0.0124; n=3). 787 
D, Immunostaining of longitudinal sections of optic nerves at P30 with anti-cleaved-788 
caspase-3 reveals increased cell apoptosis in the R-Ras1-/-;R-Ras2-/- mice compared to 789 
controls (n=3). Scale Bar=25 μm. 790 
Figure 4. Myelin decrease in the absence of R-Ras1 and/or R-Ras2. A, Coronal sections 791 
from adult (P90) mouse brains stained with DAPI show a remarkable reduction in the 792 
thickness of the corpus callosum in the double mutant compared with the control. 793 
Lower-magnification images of the corpus callosum shown in the boxed insert 794 
(interaural 4.40-4.76 mm and bregma 0.61-0.97 mm; (Paxinos and Franklin, 2013). B, 795 
Quantification of corpus callosum thickness in these coronal sections shows a decrease 796 
in R-Ras1-/-;R-Ras2-/- compared with control. Corpus callosum thickness was analyzed 797 
in several positions: position 0 in x-axis means a measurement in middle line (R-Ras1-/-798 
;R-Ras2-/ 169.7±16.5 ?m, control 428.6±43.1 ?m, p<0.0001); position 0.5 is a 799 
measurement in cingulate cortex (R-Ras1-/-;R-Ras2-/- 158.7±7.8 ?m, control 321.3±40.7 800 
?m, p=0.0002 in right, R-Ras1-/-;R-Ras2-/-  155.1±15.8 ?m, control 342.4±30.2 ?m, 801 
p<0.0001 in left); position 1 is a measurement in secondary motor cortex (R-Ras1-/-;R-802 
Ras2-/- 184.3±18.2 ?m, control 365.9±59.5 ?m, p=0.0011 in right, R-Ras1-/-;R-Ras2-/-  803 
181.8±29.9 ?m, control 408.2±41.6 ?m, p<0.0001 in left); position 1.5 is a 804 
measurement in primary motor cortex (R-Ras1-/-;R-Ras2-/- 158.9±12.3 ?m, control 805 
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305.9±66.8 ?m, p=0.005 in right, R-Ras1-/-;R-Ras2-/- 166.7±31.2 ?m, control 806 
352.5±30.3 ?m, p<0.0001 in left). C-D Dual staining of longitudinal sections of adult 807 
(P90) corpus callosum (C) and optic nerves (D) with anti-MBP and anti-NF200 (red) 808 
reveals myelin deficits in R-Ras1-/-;R-Ras2-/- mice relative to controls. E, Immunoblot 809 
of corpus callosum lysates from P90 double-mutant mice compared with controls also 810 
shows this reduction in MAG and MBP. Western blot of adult (P90) optic nerve lysates 811 
confirmed a significant decrease in the myelin marker protein expression, like MAG 812 
and MBP in single and double mutants compared to controls. (n=3). F, Significant 813 
decrease in MAG and MBP expression in the corpus callosum. Bar graph represents 814 
mean ± SD of the change relative to the control of measurements normalized to 815 
GAPDH from three different experiments: MAG R-Ras1-/-;R-Ras2-/- 72.48±15.91% 816 
(p=0.004); MBP R-Ras1-/-;R-Ras2-/- 44.52±20.53% (p<0.0001).   G, Significant 817 
decrease in MAG and MBP expression in the optic nerve. Bar graph represents mean ± 818 
SD of the change relative to the control of measurements normalized to GAPDH from 819 
three different experiments: MAG R-Ras1-/- 72.89±13.29% (p=0.0083), R-Ras2-/- 820 
63.65±9.45% (p=0.0026), R-Ras1-/-;R-Ras2-/- 52.82±13.19% (p=0.0035); MBP R-Ras1-/- 821 
69.24±18.41% (p=0.0057), R-Ras2-/- 56.36±20.54% (p=0.0014), R-Ras1-/-;R-Ras2-/- 822 
43.47±19.03% (p=0.00016). n=3. Scale Bar= 500 μm in A; 5 μm in C and D. 823 
Figure 5. Thinner myelin sheath in R-Ras1-/-, R-Ras2-/- and R-Ras1-/-;R-Ras2-/- adult 824 
(P90) mutant mice. A, Transverse sections of the optic nerve from adult (P90) control, 825 
R-Ras1-/-, R-Ras2-/- and R-Ras1-/-;R-Ras2-/- mice analyzed by electron microscopy show 826 
a significant decrease of myelin in single and double mutants compared with controls. 827 
B, Higher magnification images show no differences in myelin structure, compaction 828 
and periodicity in mutant mice compared to controls. However, R-Ras1-/-, R-Ras2-/- and 829 
more dramatically R-Ras1-/-;R-Ras2-/-, show less wrapping of myelinated axons 830 
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compared to controls. C, Scatter plots show the morphometric quantification of g-ratios 831 
(y-axis) of individual fibers relative to the respective axon diameters (x-axis) from optic 832 
nerves. Significant increase in g-ratios were found in R-Ras1-/- (0.87±0.04, p=0.000012, 833 
n=924 axons analyzed), R-Ras2-/- (0.8±0.08, p=0.000011, n=1014 axons analyzed) and 834 
R-Ras1-/-;R-Ras2-/-(0.89±0.06, p=0.000072, n=1037 axons analyzed) compared to 835 
controls (0.75±0.09, n=764 axons analyzed). D, Graph shows the percentage of 836 
myelinated axons present in the optic nerve of R-Ras1-/- = 102±2.7%, R-Ras2-/- = 837 
72.1±5.2% and R-Ras1-/-;R-Ras2-/- = 23.9±2.5% compared to the control = 100±2.8%. 838 
Significant differences were observed in the R-Ras2-/- (p<0.0001) and the double-mutant 839 
mice (p<0.0001). E, Scatter plots show the variation of myelin thickness with respect to 840 
the diameter of axons in single and double mutants compared to the control (control = 841 
251±60 nm, n=764 axons analyzed; R-Ras1-/- = 105±53 nm, p<0.0001, n=924 axons 842 
analyzed; R-Ras2-/- = 159±75 nm, p<0.0001, n=1014 axons analyzed; R-Ras1-/-;R-Ras2-843 
/- = 73±40 nm, p<0.0001, n=1037 axons analyzed). F, Graph shows the percentage of 844 
axons classified according to their diameters in control and double-mutant mice. 845 
Compared to the control, R-Ras1-/-;R-Ras2-/- mice showed a significant increase in the 846 
smallest axons, measuring less than 600 nm, (control = 30% , R-Ras1-/-;R-Ras2-/- = 847 
42.6% of axons, p<0.0001) and a significant decrease in axons measuring more than 848 
1000 nm (control = 30.3% , R-Ras1-/-;R-Ras2-/- = 21.5% of axons, p=0.0002). All 849 
samples were obtained from adult mice (P90).  n=3. Scale Bars= 500 nm in A; 250 nm 850 
in B. 851 
Figure 6. R-Ras1 and R-Ras2 play a crucial role in OL differentiation. A, Mirror 852 
images of coronal brain sections from P15 control and R-Ras1-/-;R-Ras2-/- mice 853 
immunolabeled with an anti-O4 antibody (red). Pictures correspond to the corpus 854 
callosum (interaural 2.36-2.48 mm and bregma -1.43 mm (Paxinos and Franklin, 2013). 855 
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More intense staining occurred in R-Ras1-/-;R-Ras2-/- mice, indicating an increase in the 856 
proportion of pre-myelinating OLs in double mutants relative to controls. B, Schematic 857 
representation of different O4 immunostaining observed in double mutants compared to 858 
controls. Right hemisphere represents R-Ras1-/-;R-Ras2-/- mice where the corpus 859 
callosum shows more premyelinating OLs (red) than controls (left hemisphere). C, Dual 860 
immunostaining with anti-Tcf4 (red) and anti-Olig2 (green) in the corpus callosum of 861 
P15 control (top) and R-Ras1-/-;R-Ras2-/- (bottom)  mice. Double-mutant mice showed 862 
more premyelinating OLs than controls (Tcf4/Olig2 positive cells) in P15 mice. D, 863 
Percentage of premyelinating OLs (Tcf4-positive cells) relative to the amount of OLs 864 
(Olig2-positive cells). Double-mutant mice show a significant increase in the number of 865 
immature OLs compared to controls. Bar graph represents a significant increase in the 866 
percentage of Tcf4-positive cells in double mutants compared with controls. (P15: R-867 
Ras1-/-;R-Ras2-/-=91% increase p=0.016; P30: R-Ras1-/-;R-Ras2-/-=155% increase, 868 
p=0.002 and P120: R-Ras1-/-;R-Ras2-/-=70% increase, p=0.017) (n=3). E, Double 869 
immunostaining with anti-CC1 (red) and anti-Olig2 (green) in the corpus callosum of 870 
P120 control (top) and R-Ras1-/-;R-Ras2-/- (bottom)  mice. Double-mutant mice showed 871 
a drastic reduction in the proportion of mature OLs compared with the controls 872 
(CC1/Olig2 positive cells). F, Quantification of the percentage of mature OLs 873 
(CC1positive cells) relative to the total amount of OLs (Olig2 positive cells). A 874 
significant decrease in the percentage of CC1 positive cells was found in double 875 
mutants compared with controls (R-Ras1-/-;R-Ras2-/-=57.3% decrease p=0.0006 (n=3). 876 
G, Representative confocal images of morphologies found in primary cultures stained 877 
for CNPase (green) and Olig2 (red). After 14 DIV, OLs from double mutants show 878 
simpler morphology than controls. H, Schematic representation of enriched primary OL 879 
cultures from the cortex of control and R-Ras1-/-;R-Ras2-/- mice shows a simpler 880 
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morphology in double mutants. Proportion of OLs (CNPase and Olig2 positive cells) 881 
with simple and complex processes are shown for each genotype in the bar graph. Most 882 
double-mutant OLs had simple processes (72.85±12.7%, n=101 OLs quantified) that 883 
differed significantly from controls (27.15±12.7%, p= 0.0106, n=121 OLs quantified). 884 
A few double-mutant OLs had complex processes (24.9±13.3%) that differed 885 
significantly from controls (75.1±13.3%, p=0.0106). Scale Bars: 250 μm in A; 25 μm in 886 
C and E. 887 
Figure 7. More nodes of Ranvier with shorter length generate more internodes in the 888 
absence of R-Ras1 and R-Ras2 in adult mice (P90). A, Double-staining of longitudinal 889 
sections of adult (P90) optic nerves with anti-Caspr (green) and anti-NF200 (red) reveal 890 
an increase in the number of paranodes (green) in the R-Ras1-/-;R-Ras2-/- mice compared 891 
to controls. The distance between paranodes (nodal length) in higher magnification 892 
images (boxed insert) was shorter in double mutants than in controls. B, Simplified 893 
scheme representing the node of Ranvier between two internodes. C, Western blot of 894 
P90 optic nerve lysates shows a significant increase in Caspr protein expression in 895 
double mutants compared to controls. Bar graph shows the mean ± SD change in 896 
densitometric measurements normalized to GAPDH and relative to controls (p=0.016; 897 
n=5). D, Schematic representation of the shorter nodal length and more internodes 898 
observed in the R-Ras1-/-;R-Ras2-/- mice compared to control. E, Bar graph shows a 899 
significant increase in paranodes found in double mutants (80.85±19.71 900 
paranodes/67x67μm) compared to controls (54.09±14.22 paranodes/67x67μm) (p= 901 
0.000124; n=4). F, Paranodal length classification does not reveal any differences in R-902 
Ras1-/-;R-Ras2-/- compared with controls. G, Node classification by their length reveals 903 
more short nodes in R-Ras1-/-;R-Ras2-/- mice (30.5±4.5% of nodes <0.5 μm long) than 904 
in controls (7.5±5.1% of nodes <0.5 μm long, p=0.004) at the expense of longer nodes.  905 
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Figure 8. Axonal conduction velocity was affected by the absence of R-Ras1 and/or R-906 
Ras2. A, Experimental design. Alert-behaving mice received a photic stimulator (flash) 907 
through a stroboscope located 30 cm in from of them. B, Recording electrodes 908 
implanted in the left dorsal lateral geniculate nucleus. Photomicrograph illustrates 909 
recording electrode location. C, Examples of field potentials evoked by light flash 910 
stimulation at the dorsal lateral geniculate nucleus. Recordings averaged 20 times and 911 
collected from representative control, R-Ras1-/-, R-Ras2-/-, and R-Ras1-/-;R-Ras2-/- mice. 912 
Light flash presentation indicated by an arrow. Latency to P1 and to the latest N 913 
component of the evoked field potential indicated. D, E, Although no significant 914 
differences were observed for latency values from flash presentation to P1, latency 915 
values to the last N component of the evoked field potential were significantly larger for 916 
the three experimental groups (R-Ras1-/-, R-Ras2-/-, and R-Ras1-/-;R-Ras2-/-) compared 917 
with controls. ***, p<0.001. All mice analyzed were adults (P120). 918 
919 
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